Sort
15,842 grants matching “pancreatic cancer”
Receptor-Targeted Fluorescence-Guided Surgery in Pancreatic Neuroendocrine Tumors
$628,150Ali Azhdarinia · University Of Texas Hlth Sci Ctr Houston · R01 · FY2023 · CA
The Oral Mycobiome and Risk of Pancreatic Cancer
$627,816Jiyoung Ahn · New York University School Of Medicine · U01 · FY2022 · CA
Mitochondrial calcium signaling in pancreatic cancer metastasis and progression
$627,740Shengyu Yang · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2023 · CA
Optimizing Theranostic Dosimetry and Kidney Biomarkers for Alpha-Emitter Radioligand Therapy in Neuroendocrine Tumors
$627,573Diana Zepeda-Orozco · Research Inst Nationwide Children'S Hosp · R01 · FY2024 · CA
Building protected data sharing networks to advance cancer risk assessment and treatment
$627,513Ian Foster · University Of Chicago · U24 · FY2021 · CA
Validation and Fine-Scale Mapping of Pancreatic Cancer Susceptibility Loci (Study)
$627,443Alison P Klein · Johns Hopkins University · R01 · FY2020 · CA
Disparities in access to and outcomes of cancer surgery for rural Medicare patients
$627,289Anna N. A. Tosteson · Dartmouth College · R01 · FY2023 · CA
Engineering self-propelled tumor-infiltrating CAR T cells using synthetic velocity receptors
$627,272Denis Wirtz · Johns Hopkins University · R01 · FY2025 · CA
A Dose Expansion Study of SX-682 Alone and in Combination with Decitabine in MDS Patients
$627,270Aaron D Schuler · Syntrix Biosystems, Inc. · R44 · FY2025 · CA
Great Lakes New England Clinical Validation Center
$627,186Dean E. Brenner · University Of Michigan At Ann Arbor · U01 · FY2021 · CA
Merging Marine-Derived Cytotoxic Natural Products With Experimental Therapeutics
$626,963Phil Crews · University Of California Santa Cruz · R01 · FY2014 · CA
Management and Data Coordination Unit for PCDC
$626,858Ann Laura Oberg · Mayo Clinic Rochester · U24 · FY2024 · CA
Lysosome Trapped FAP-Targeted Theranostics for Pancreatic Cancer
$626,716Jered C Garrison · University Of Nebraska Medical Center · R01 · FY2025 · CA
Detecting cancer early with targeted nano-probes for va*
$626,605Douglas Hanahan · University Of California, San Francisco · R01 · FY2006 · CA
Understanding Efficacy and Fe(II)-Promoted Activation of 1,2,4-Trioxolanes in Cancer
$626,596Eric Collisson · University Of California, San Francisco · R01 · FY2022 · CA
P-selectin-Mediated Targeting of PI3K Nanomedicines to the Tumor Microenvironment
$626,484Daniel Alan Heller · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA
Mechanobiology
$626,432Alexander Cartagena-Rivera · National Institute Of Biomedical Imaging And Bioengineering · ZIA · FY2022 · EB
Urine and serum biomarkers for early diagnosis and risk assessment of pancreatic cancer
$626,416Anna E Lokshin · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · CA
FANCONI ANEMIA:GENOTYPE-PHENOTYPE CORRELATIONS
$626,078Elaine Ostrander · National Human Genome Research Institute · ZIA · FY2012 · HG
Mechanisms of the Gain-of-functions of p53 mutants and the effects by USP7 PROTAC
$625,801Wei Gu · Icahn School Of Medicine At Mount Sinai · P01 · FY2025 · CA
Integrating Epigenetic Modulation into DNA Damage Repair
$625,664Pamela N Munster · University Of California, San Francisco · R01 · FY2024 · CA
Subpopulations of Pancreatic Cancer Cells Defined by Glycan Markers
$625,227Brian B Haab · Van Andel Research Institute · U01 · FY2021 · CA
Understanding Efficacy and Fe(II)-Promoted Activation of 1,2,4-Trioxolanes in Cancer
$625,125Eric Collisson · University Of California, San Francisco · R01 · FY2023 · CA
Chemical tools for developmental biology
$625,036James K Chen · Stanford University · R35 · FY2024 · GM
Chemical tools for developmental biology
$625,036James K Chen · Stanford University · R35 · FY2025 · GM